Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 1 1

Status

Active not recruiting 4

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 4

Conditions

Carcinoma, Non-Small-Cell Lung 4

Interventions

Carboplatin 6amivantamab 4Pemetrexed 4osimertinib 3lazertinib 3Specimen Handling 3Prednisone 3Nivolumab 3Ado-Trastuzumab Emtansine 3trastuzumab deruxtecan 2talquetamab 2pertuzumab 2pembrolizumab 2niraparib 2ipatasertib 2eribulin 2erdafitinib 2entrectinib 2belzutifan 2atezolizumab 2apalutamide 2alectinib 2acalabrutinib 2Vinorelbine 2Trastuzumab 2Sunitinib 2Rituximab 2Paclitaxel 2Midazolam 2Magnetic Resonance Spectroscopy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Has announcements × Pemetrexed × 30 days × Clear all
NCT02609776 2026-05-08

CHRYSALIS

Janssen Research & Development, LLC

Phase 1 Active not recruiting
751 enrolled 1 FDA
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04538664 2026-05-08

PAPILLON

Janssen Research & Development, LLC

Phase 3 Active not recruiting
308 enrolled 12 charts 1 FDA
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04988295 2026-05-08

MARIPOSA-2

Janssen Research & Development, LLC

Phase 3 Active not recruiting
776 enrolled 13 charts 1 FDA
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03456076 2026-05-05

A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer

Hoffmann-La Roche

Phase 3 Active not recruiting
257 enrolled 14 charts 1 FDA
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡